Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for malaria treatment by type
5.1 Antimalarial agents (quinine, chloroquine, proguanil, mefloquine, pyrimethamine, others)
5.1.1 Market size and forecast
5.2 Diagnostic test (rapid diagnostic tests, microscopy, molecular diagnostic tests)
5.2.1 Market size and forecast

Part 6. Global market for malaria treatment by route of administration
6.1 Oral
6.1.1 Market size and forecast
6.2 Parenteral
6.2.1 Market size and forecast

Part 7. Global market for malaria treatment by end user
7.1 Hospitals
7.1.1 Market size and forecast
7.2 Specialty clinics
7.2.1 Market size and forecast
7.3 Others
7.3.1 Market size and forecast

Part 8. Global market for malaria treatment by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast

Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 Advanz Pharma Corp.
9.3 Bayer AG
9.4 bioMerieux SA
9.5 Bio-Rad Laboratories, Inc.
9.6 Cadila Healthcare Limited
9.7 F. Hoffmann-La Roche Ltd.
9.8 GlaxoSmithKline plc
9.9 Glenmark Pharmaceuticals Limited
9.10 Ipca Laboratories Limited
9.11 Merck & Co., Inc.
9.12 Meridian Bioscience Inc.
9.13 Novartis International AG
9.14 Olympus Corporation
9.15 Pfizer Inc.
9.16 Sanofi S.A.
9.17 Sun Pharmaceutical Industries Ltd.
9.18 Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY